• Use in patients with significantly impaired hepatic function (Child-Pugh class C)• Use in patients with severe renal impairment• Use in patients with clinically significant or uncontrolled cardiac disease, including congestive heart failure (NYHA functional classification of ≥2), angina requiring treatment, myocardial infarction within the past 12 months, or ventricular arrhythmia requiring treatment or intervention"